Proteomic biomarkers of endometrial cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration

References

• Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reprod 2004;19:41–7
   PubMed Web of Science ®Google Scholar
• Wild RA. Long term health consequences of PCOS. Human Reprod Update 2002;8:231–41
   PubMed Web of Science ®Google Scholar
• Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Ann Rev Med 2001;52:401–19
   PubMed Web of Science ®Google Scholar
• Fearnley EJ, Marquart L Spurdle AB; Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group, et al. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control 2010;21:2303–8
   PubMed Web of Science ®Google Scholar
• Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009;19:398–405
   PubMed Web of Science ®Google Scholar
• Pillay OC, Te Fong LF, Crow JC, et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006;21:924–9
   PubMed Web of Science ®Google Scholar
• Hardiman P, Pillay OS, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 2003;361:1810–2
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 1998;11:1853–61
   Google Scholar
• Atiomo WU, Khalid S, Ziauddin A, et al. Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome. Special report. Expert Rev Proteomics 2009;6:469–99
   PubMed Web of Science ®Google Scholar
• Zaino RJ. FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol 2009;28:1–9
   PubMed Web of Science ®Google Scholar
• Parker LA, Gómez Saez N, Lumbreras B, et al. Methodological deficits in diagnostic research using ‘-omics' technologies: evaluation of the QUADOMICS tool and quality of recently published studies. PLoS One 2010;5:e11419
   Web of Science ®Google Scholar
• Choi DH, Lee WS, Won M, et al. The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis. J Proteome Res 2010;9:4329–36
   PubMed Web of Science ®Google Scholar
• Insenser M, Martinez-Garcia MA, Montes R, et al. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation. J Clin Endocrinol Metab 2010;95:3863–70
   PubMed Web of Science ®Google Scholar
• Misiti S, Stigliano A, Borro M, et al. Proteomic profiles in hyperandrogenic syndromes. J Endocrinol Invest 2010;33:156–64
   PubMed Web of Science ®Google Scholar
• Atiomo W, Khalid S, Parameshweran S, et al. Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review. BJOG 2009;116:137–43
   PubMed Web of Science ®Google Scholar
• Santillan I, Neubeck S, Markert UR. Comparative proteomic analysis of follicular fluids from patients with different infertility etiologies. Am J Reprod Immunol 2010;63:52–3
   Google Scholar
• Webber M, Neubeck S, Hoppe I, Markert UR. Comparative proteomic analysis of follicular fluids from patients with different infertility etiologies. J Reprod Immunol 2010;86:56–7
   Web of Science ®Google Scholar
• Cox MC, Borro M, Gentile G, et al. Specific effects exerted by B-lymphoproliferative diseases on peripheral T lymphocytes protein expression. Haematologica 2010;95:176–7
   Web of Science ®Google Scholar
• Baek KH, Kim YS, Gu BH, et al. Apolipoprotein as a novel gene associated with polycystic ovary syndrome. Fertil Steril 2010;94;4:S197–8
   Google Scholar
• Ling J, Zhao KK, Cui YG, et al. Heat shock protein 10 regulated apoptosis of mouse ovarian granulosa cells. Gynecol Endocrinol 2011;27:63–71
   PubMed Web of Science ®Google Scholar
• Peral B, Camafeita E, Fernandez-Real JM. Tackling the human adipose tissue proteome to gain insight into obesity and related pathologies. Expert Rev Proteomics 2009;6:353–61
   PubMed Web of Science ®Google Scholar
• Hojlund K, Mogensen M, Sahlin K. Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinol Metab Clin North Am 2008;37:713--31
   PubMed Web of Science ®Google Scholar
• DeSouza L, Diehl G, Rodrigues MJ, et al. Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 2005;4:377–86
   PubMed Web of Science ®Google Scholar
• Wahl H, Daudi S, Kshirsagar M, et al. Expression of metabolically targeted biomarkers in endometrial carcinoma. Gynecol Oncol 2010;116:21–7
   PubMed Web of Science ®Google Scholar
• Monge M, Doll A, Colas E, et al. Subtractive proteomic approach to the endometrial carcinoma invasion front. J Proteome Res 2009;8:4676–84
   PubMed Web of Science ®Google Scholar
• Negishi A, Ono M, Handa Y, et al. Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry. Cancer Sci 2009;100:514–9
   PubMed Web of Science ®Google Scholar
• DeSouza LV, Krakovska O, Darfler MM, et al. mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues. Proteomics 2010;10:3108–16
   PubMed Web of Science ®Google Scholar
• Guo J, Yang EC, Desouza L, et al. A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma. Proteomics 2005;5:1953–66
   PubMed Web of Science ®Google Scholar
• Li Z, Huang C, Bai S, et al. Prognostic evaluation of epidermal fatty acid-binding protein and calcyphosine, two proteins implicated in endometrial cancer using a proteomic approach. Int J Cancer 2008;123:2377–83
   PubMed Web of Science ®Google Scholar
• Li Z, Zhao X, Bai S, et al. Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Mol Cell Proteomics 2008;7:1810–23
   PubMed Web of Science ®Google Scholar
• DeSouza LV, Grigull J, Ghanny S, et al. Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2007;6:1170–82
   PubMed Web of Science ®Google Scholar
• Dubé V, Grigull J, DeSouza LV, et al. Verification of endometrial tissue biomarkers previously discovered using mass spectrometry-based proteomics by means of immunohistochemistry in a tissue microarray format. J Proteome Res 2007;6:2648–55
   PubMed Web of Science ®Google Scholar
• Stefansson IM, Salvesen HB, Akslen LA. Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients. Int J Cancer 2006;118:1227–33
   PubMed Web of Science ®Google Scholar
• Velasco A, Pallares J, Santacana M, et al. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma. Hum Pathol 2011;42:185--93
   Google Scholar
• Kinnula K, Linnainmaa K, Raivio KO, Kinnula VL. Endogenous antioxidant enzymes and glutathione S.transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity. Br J Cancer 1998;77:1097–102
   PubMed Web of Science ®Google Scholar
• Gasque P. Complement: a unique innate immune sensor for danger signals. Mol Immunol 2004;41:1089–98
   PubMed Web of Science ®Google Scholar
• Jin ZG, Lungu AO, Xie L, et al. Cyclophilin A is a proinflammatory cytokine that activates endothelial cells. Atheroscler Thromb Vasc Biol 2004;24:1186--91
   PubMed Web of Science ®Google Scholar
• Assinder SJ, Stanton JAL, Prasad PD. Transgelin: an actin-binding protein and tumour suppressor. Int J Biochem Cell Biol 2009;4:482–6
   Google Scholar
• Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 2005;15:300–8
   PubMed Web of Science ®Google Scholar
• Nomura H, Uzawa K, Ishigami T, et al. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity. BMC Cancer 2008;8:39
   PubMed Web of Science ®Google Scholar
• Tanaka K, Sakoda K, Akita H. Studies on leucine aminopeptidase isoenzymes from the clinical and biochemical aspects. Jpn J Gastroenterol 1979;76:1677–87
   PubMedGoogle Scholar
• Dhindsa G, Bhatia R, Dhindsa M, Bhatia V. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome. J Postgrad Med 2004;50:140–4
   PubMedGoogle Scholar
• Ptolemy P, Rifai N. What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scand J Clin Lab Invest Suppl 2010;70:6–14
   Google Scholar
• Dudley JT, Butte AJ. Identification of discriminating biomarkers for human disease using integrative network biology. Pacific Symp Biocomput 2009;14:27–38
   Google Scholar
• Hlatky MA, Greenland P, Arnett DK; on behalf of the American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009;119:2408–16
   PubMed Web of Science ®Google Scholar